Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

702
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
702
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

792
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
792
Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

575
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
575
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

1.2K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

491
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
491

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GWAS of Second-Generation Antihistamine Use: Locus Specificity and Highlighted Signalling Pathways.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Fine-Mapping of HLA Effects in Oral and Non-Oral Lichen Planus.

HLA·2026
Same author

Qualified prediction system for allograft failure in real world settings: extended validation study.

BMJ medicine·2026
Same author

Genome-wide association study identifies protective genetic factors in active blood donors against multiple diseases.

European journal of human genetics : EJHG·2026
Same author

Pan-cancer polygenic risk score associates with cancer susceptibility following kidney transplantation.

JCI insight·2026
Same author

Clinical outcomes after liver transplantation using donor grafts with SERPINA1 Z heterozygosity.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Value of Genetically Rare Cord Blood Units Beyond Conventional Quality Metrics.

HLA·2026
Same journal

Characterisation of the Novel HLA-B*07:05:15 Allele by Sequencing-Based Typing.

HLA·2026
Same journal

Identification of the Novel HLA-C*03:536:02 Allele in a Chinese Cord Blood Donor.

HLA·2026
Same journal

Characterisation of the Novel HLA-DQB1*03:618 Allele by Sequencing-Based Typing.

HLA·2026
Same journal

Identification of the Novel HLA-A*01:510 Allele Through Next-Generation Sequencing.

HLA·2026
Same journal

Identification of the HLA-B*07:02:112 Allele in a Brazilian Individual by Next-Generation Sequencing.

HLA·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.9K

Non-Classical HLA and MIC Risk Score Is Associated With Acute Kidney Transplant Rejection Beyond Classical HLA

Silja Tammi1, Salla Markkinen1, Ilkka Helanterä2

  • 1Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland.

HLA
|April 2, 2026
PubMed
Summary
This summary is machine-generated.

Polymorphisms in non-classical HLA and MIC genes predict kidney transplant rejection risk. An oligogenic score using these genes improves risk assessment beyond standard matching, aiding graft allocation.

Keywords:
MICacute rejectionnon‐classical HLArisk score

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.7K
Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
09:04

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

Published on: April 19, 2017

14.1K

Related Experiment Videos

Last Updated: Apr 3, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

21.9K
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.7K
Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
09:04

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

Published on: April 19, 2017

14.1K

Area of Science:

  • Immunogenetics
  • Transplantation immunology
  • Genomic risk prediction

Background:

  • Human Leukocyte Antigen (HLA) matching is crucial for kidney transplant success.
  • Non-classical HLA and MIC genes' role in transplant outcomes is not well understood.
  • Polymorphisms in these genes may influence acute rejection risk.

Purpose of the Study:

  • To investigate the contribution of non-classical HLA and MIC gene polymorphisms to acute kidney transplant rejection.
  • To develop and validate an oligogenic risk score for predicting transplant outcomes.

Main Methods:

  • Developed an oligogenic risk score using ten polymorphisms in HLA-E, -F, -G, MICA, and MICB genes.
  • Validated the score in a retrospective cohort of 1025 Finnish kidney transplant recipients.
  • Utilized Cox proportional hazards analysis to assess association with time to acute rejection.

Main Results:

  • The oligogenic risk score was significantly associated with rejection-free survival in both discovery and replication cohorts.
  • The score demonstrated added value beyond standard HLA-A, -B, -DRB1 matching and eplet matching.
  • The score effectively differentiated high-risk and low-risk patient groups.

Conclusions:

  • Non-classical HLA and MIC gene polymorphisms are valuable in kidney transplant risk assessment.
  • Oligogenic and polygenic scores can predict transplant outcomes and inform graft allocation.
  • Incorporating these genetic markers may optimize immunosuppression strategies and improve graft survival.